0001997038-24-000001.txt : 20240425 0001997038-24-000001.hdr.sgml : 20240425 20240425152014 ACCESSION NUMBER: 0001997038-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240425 DATE AS OF CHANGE: 20240425 EFFECTIVENESS DATE: 20240425 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Iambic Therapeutics, Inc. CENTRAL INDEX KEY: 0001997038 ORGANIZATION NAME: IRS NUMBER: 843364168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-511607 FILM NUMBER: 24875673 BUSINESS ADDRESS: STREET 1: 5627 OBERLIN DRIVE, SUITE 120 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (626) 592-2520 MAIL ADDRESS: STREET 1: 5627 OBERLIN DRIVE, SUITE 120 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0001997038 Iambic Therapeutics, Inc. 5627 OBERLIN DRIVE, SUITE 120 SAN DIEGO CA CALIFORNIA 92121 (626) 592-2520 DELAWARE Entos, Inc. None Corporation true 2019 Thomas Miller c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Executive Officer Director Fred Manby c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Executive Officer Director Neil Josephson c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Executive Officer Tabbert Teng c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Executive Officer Evan Rachlin c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Director Kurt von Emster c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Director R. Jacob Vogelstein c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Director Jishnu Bhattacharjee c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Director William Rastetter c/o Iambic Therapeutics, Inc. 5627 Oberlin Drive, Suite 120 San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b false 2024-04-15 false true false 0 37999999 26874991 11125008 false 7 0 0 0 false Iambic Therapeutics, Inc. /s/ Thomas Miller Thomas Miller Chief Executive Officer 2024-04-24